
India Pesticides shares surged nearly 15% during Wednesday's trading session following the announcement of regulatory approvals in the UK and Argentina. The stock was trading ₹140.9 per share with gains of around 6.2% at ₹140.9, after hitting an intraday high of ₹152.28 and touching a low of ₹125. The rally comes after the company secured Technical Equivalence approval for an insecticide product in the United Kingdom and registration for a herbicide product in Argentina, both dated September 15, 2026. The approvals mark significant milestones in the company's international growth journey and strengthen its presence in the global agrochemical market.
India Pesticides reported net profit of ₹23.07 crore in the June quarter of financial year 2026-27, compared to ₹31.76 crore in the March quarter. The company's quarterly revenue from operations fell to ₹252.56 crore in Q1 FY27 against ₹266.15 crore reported in the March quarter. The earnings per share (EPS) declined to ₹2.00 in Q1 FY27 against ₹2.60 in Q4 FY26. Despite recent quarterly challenges, the company had crossed the ₹1,000 crore milestone with consolidated revenue of ₹1,057.42 crore for the full financial year ended March 31, 2026, demonstrating strong long-term growth trajectory.
Commenting on the regulatory milestone, Dheeraj Kumar Jain, Chief Executive Officer stated that these approvals are aligned with the company's strategy of increasing contribution from international markets and building a diversified export portfolio. As per Business Standard, Jain emphasized that access to the United Kingdom and Argentina will enable the company to engage with new customers and commercialise products across additional geographies. The CEO indicated that the company will continue to invest in regulatory registrations and product development to scale its global business and create long-term value for stakeholders.
The stock has shown mixed performance with an 8.65% rise over two weeks but a 15.25% decline in 2026 so far. India Pesticides shares were trading at ₹132.25 on BSE as of the latest data, compared to the previous close of ₹133.70. The stock had closed at ₹132.78 apiece on September 15, down 0.68% or ₹0.91 from the previous close. The company's stock touched its 52-week high of ₹240.10 per share on September 8, 2025, and dipped to its 52-week low of ₹124.65 per share on March 30, 2026. With a return on equity (ROE) of 16.79%, the stock value has surged around 8.25% in one week and 7.74% in two weeks.
At the end of the June quarter, promoters held 63.6% shareholding in India Pesticides, while Foreign Institutional Investors (FIIs) had a 2.52% stake. Nearly 34% of the company is owned by public shareholders, with domestic institutions not having any significant shareholding. The company has been expanding its international presence, having received technical equivalence approval in the European Union for one of its fungicide products in July 2026. These approvals in high-barrier regulated markets like the UK and Argentina represent solid catalysts for medium-term export volume growth, with the company expecting these milestones to support export growth and contribute positively to foreign exchange earnings.